Depression is debilitating, painful and, unfortunately, common, affecting 1 in 10 Canadians. Despite the availability of antidepressant options, discovering an effective treatment often entails a prolonged process of trial and error.⁣ ⁣ That may soon change, however, with the rise of pharmacogenomic testing that can provide information about how effective a drug will be, based on a person’s DNA.⁣ ⁣ More than half of patients do not respond to the antidepressant they are first prescribed, according to Dr. Jehannine Austin, professor of medical genetics and psychiatry, and Dr. Shahzad Ghanbarian, mathematical modeler at the Centre for Clinical Epidemiology and Evaluation at UBC.⁣ ⁣ Read more about how pharmacogenomic testing holds the promise of faster, effective treatment, and how to access it via the link in our bio.⁣ ⁣ #MentalHealth #Depression #Genetics #GeneticCounseling #GeneticTesting